We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Randox Laboratories

Provides global diagnostic solutions for hospital laboratories, forensic laboratories, research laboratories, pharmac... read more Featured Products: More products

Download Mobile App




New Supermix Controls to Streamline QC in Clinical Laboratories

By LabMedica International staff writers
Posted on 20 Mar 2014
Two new liquid assayed chemistry controls have been designed to streamline quality control (QC) by cutting the number of individual QCs a laboratory needs to run in routine medical testing, saving time and money while ensuring highly accurate results and patient diagnosis.

The two new controls, Acusera liquid assayed Liquid Chemistry Premium and Liquid Chemistry Premium Plus from Randox Laboratories (Antrim, North Ireland, UK), enable laboratories to run QC on up to 100 analytes all within one test, without compromising performance or accuracy. More...
The concept of offering multianalyte controls is not new; however, these latest assayed controls from Randox are the most comprehensive on the world market to date, containing a unique supermix combination of proteins, lipids, immunoassays, cardiac markers, blood markers, therapeutic drugs, and routine chemistry analytes.

Available in 3 concentration levels (low, mid, and high), Premium Plus covers a very broad clinical range, removing the need for laboratories to purchase additional, often expensive, low or high level controls. The Acusera Liquid Chemistry Premium Plus control contains 100 analytes, while the Acusera "Liquid Chemistry Premium" control offers 91, with the following features. The high levels of CRP and other key proteins included eliminate the need for multiple controls, dramatically streamlining QC. They are assayed controls, providing clinically significant values for a wide range of analyzers at key decision points. Both controls are liquid for ease of use, eliminating possible reconstitution errors and improving lab efficiency. The controls are highly stable when stored at -20 °C to -70 °C, with open vial stability of up to 7 days at 2–8 °C, reducing wastage in laboratories. They are manufactured using human-based serum, ensuring performance that closely mirrors patient samples.

As true third party controls, laboratories are far better assured of unbiased, independent assessment of analytical performance and as such help deliver highly accurate results and patient diagnosis.

"These new assayed controls will be hugely beneficial to medical laboratories running a wide range of routine patient tests, allowing them to consolidate all or the majority of their QC within one control," said Dr. John Campbell, PhD. Steven Jordan, Randox’s Global Manager for QC, said, "Randox reputation as a leading global provider of quality controls takes another step forward with the launch of Acusera Liquid Chemistry Premium and Premium Plus. We’re delighted to be pushing the boundaries of quality control, helping laboratories improve their performance and productivity whilst ensuring highly accurate results and improving patient diagnosis."

The controls are now available in the UK, Europe, Middle East, Far East, and Africa. Randox is currently awaiting product approval from the US FDA and China SFDA.

Related Links:

Randox Laboratories
Acursera Liquid QC  



New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Clinical Chemistry System
P780
New
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Platelets sequester cfDNA during circulation (Murphy L. et al., Science, 2025; DOI: 10.1126/science.adp3971)

Platelets Could Improve Early and Minimally Invasive Detection of Cancer

Platelets are widely recognized for their role in blood clotting and scab formation, but they also play a crucial role in immune defense by detecting pathogens and recruiting immune cells.... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
image: Researchers Marco Gustav (right) and MD Nic G. Reitsam (left) discuss the study data (Photo courtesy of Anja Stübner/EKFZ)

AI Model Simultaneously Detects Multiple Genetic Colorectal Cancer Markers in Tissue Samples

Colorectal cancer is a complex disease influenced by multiple genetic alterations. Traditionally, studies and diagnostic tools have focused on predicting only one mutation at a time, overlooking the interplay... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.